;PMID: 9615223
;source_file_2918.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..35] = [t:0..35]
;1)sentence:[e:41..135] = [t:41..135]
;2)section:[e:139..197] = [t:139..197]
;3)section:[e:201..305] = [t:201..305]
;4)sentence:[e:309..508] = [t:309..508]
;5)sentence:[e:509..666] = [t:509..666]
;6)sentence:[e:667..911] = [t:667..911]
;7)sentence:[e:912..1142] = [t:912..1142]
;8)sentence:[e:1143..1273] = [t:1143..1273]
;9)sentence:[e:1274..1421] = [t:1274..1421]
;10)section:[e:1425..1469] = [t:1425..1469]

;section 0 Span:0..35
;Genomics.  1998 May 1;49(3):385-93.
(SEC
  (FRAG (NNP:[0..8] Genomics) (.:[8..9] .) (CD:[11..15] 1998) (NNP:[16..19] May)
        (CD:[20..25] 1;49-LRB-) (CD:[25..26] 3) (-RRB-:[26..27] -RRB-)
        (::[27..28] :) (CD:[28..31] 385) (::[31..32] -) (CD:[32..34] 93)
        (.:[34..35] .)))

;sentence 1 Span:41..135
;Duplication of the DR3 gene on human chromosome 1p36 and its deletion in
;human  neuroblastoma.
;[41..52]:variation-type:"Duplication"
;[60..63]:gene-rna:"DR3"
;[89..93]:variation-location:"1p36"
;[102..110]:variation-type:"deletion"
;[121..134]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[41..52] Duplication))
      (PP (IN:[53..55] of)
        (NP (DT:[56..59] the) (NN:[60..63] DR3) (NN:[64..68] gene)))
      (PP-LOC (IN:[69..71] on)
        (NP (JJ:[72..77] human) (NN:[78..88] chromosome) (NN:[89..93] 1p36))))
    (CC:[94..97] and)
    (NP
      (NP (PRP$:[98..101] its) (NN:[102..110] deletion))
      (PP (IN:[111..113] in)
        (NP (JJ:[114..119] human) (NN:[121..134] neuroblastoma))))
    (.:[134..135] .)))

;section 2 Span:139..197
;Grenet J, Valentine V, Kitson J, Li H, Farrow SN, Kidd VJ.
(SEC
  (FRAG (NNP:[139..145] Grenet) (NNP:[146..148] J,) (NNP:[149..158] Valentine)
        (NNP:[159..160] V) (,:[160..161] ,) (NNP:[162..168] Kitson)
        (NNP:[169..171] J,) (NNP:[172..174] Li) (NNP:[175..177] H,)
        (NNP:[178..184] Farrow) (NNP:[185..187] SN) (,:[187..188] ,)
        (NNP:[189..193] Kidd) (NNP:[194..197] VJ.)))

;section 3 Span:201..305
;Department of Tumor Cell Biology, St. Jude Children's Research Hospital, 
;Memphis, Tennessee 38101, USA.
(SEC
  (FRAG (NNP:[201..211] Department) (IN:[212..214] of) (NNP:[215..220] Tumor)
        (NNP:[221..225] Cell) (NNP:[226..233] Biology) (,:[233..234] ,)
        (NNP:[235..238] St.) (NNP:[239..243] Jude) (NNP:[244..252] Children)
        (POS:[252..254] 's) (NNP:[255..263] Research) (NNP:[264..272] Hospital)
        (,:[272..273] ,) (NNP:[275..282] Memphis) (,:[282..283] ,)
        (NNP:[284..293] Tennessee) (CD:[294..299] 38101) (,:[299..300] ,)
        (NNP:[301..304] USA) (.:[304..305] .)))

;sentence 4 Span:309..508
;The human DR3 gene, whose product is also known as Wsl-1/APO-3/TRAMP/LARD, 
;encodes a tumor necrosis factor-related receptor that is expressed primarily
;on  the surface of thymocytes and lymphocytes.
;[319..322]:gene-rna:"DR3"
;[360..365]:gene-protein:"Wsl-1"
;[366..371]:gene-protein:"APO-3"
;[372..377]:gene-protein:"TRAMP"
;[378..382]:gene-protein:"LARD"
;[395..433]:gene-protein:"tumor necrosis factor-related receptor"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[309..312] The) (JJ:[313..318] human) (NN:[319..322] DR3)
          (NN:[323..327] gene))
      (,:[327..328] ,)
      (SBAR
        (WHNP-1 (WP$:[329..334] whose) (NN:[335..342] product))
        (S
          (NP-SBJ-1 (-NONE-:[342..342] *T*))
          (VP (VBZ:[343..345] is)
            (ADVP (RB:[346..350] also))
            (VP (VBN:[351..356] known)
              (NP-1 (-NONE-:[356..356] *))
              (PP (IN:[357..359] as)
                (NP (NN:[360..365] Wsl-1) (SYM:[365..366] /)
                    (NN:[366..371] APO-3) (SYM:[371..372] /)
                    (NN:[372..377] TRAMP) (SYM:[377..378] /)
                    (NN:[378..382] LARD))))))))
    (,:[382..383] ,)
    (VP (VBZ:[385..392] encodes)
      (NP
        (NP (DT:[393..394] a)
          
          (ADJP
            (NML (NN:[395..400] tumor) (NN:[401..409] necrosis)
                 (NN:[410..416] factor))
            (HYPH:[416..417] -) (VBN:[417..424] related))
          (NN:[425..433] receptor))
        (SBAR
          (WHNP-2 (WDT:[434..438] that))
          (S
            (NP-SBJ-2 (-NONE-:[438..438] *T*))
            (VP (VBZ:[439..441] is)
              (VP (VBN:[442..451] expressed)
                (NP-2 (-NONE-:[451..451] *))
                (ADVP (RB:[452..461] primarily))
                (PP (IN:[462..464] on)
                  (NP
                    (NP (DT:[466..469] the) (NN:[470..477] surface))
                    (PP (IN:[478..480] of)
                      (NP (NNS:[481..491] thymocytes) (CC:[492..495] and)
                          (NNS:[496..507] lymphocytes)))))))))))
    (.:[507..508] .)))

;sentence 5 Span:509..666
;DR3 is capable of inducing both  NF-kappa B activation and apoptosis when
;overexpressed in mammalian cells,  although its ligand has not yet been
;identified.
;[509..512]:gene-rna:"DR3"
;[542..552]:gene-protein:"NF-kappa B"
(SENT
  (S
    (NP-SBJ (NN:[509..512] DR3))
    (VP (VBZ:[513..515] is)
      (ADJP-PRD (JJ:[516..523] capable)
        (PP (IN:[524..526] of)
          (S-NOM
            (NP-SBJ (-NONE-:[526..526] *))
            (VP (VBG:[527..535] inducing)
              (NP (CC:[536..540] both)
                (NP
                  (NML (NN:[542..550] NF-kappa) (NN:[551..552] B))
                  (NN:[553..563] activation))
                (CC:[564..567] and)
                (NP (NN:[568..577] apoptosis)))
              (SBAR-ADV
                (WHADVP-1 (WRB:[578..582] when))
                (S
                  (NP-SBJ-2 (-NONE-:[582..582] *))
                  (VP (VBN:[583..596] overexpressed)
                    (NP-2 (-NONE-:[596..596] *))
                    (PP-LOC (IN:[597..599] in)
                      (NP (JJ:[600..609] mammalian) (NNS:[610..615] cells)))
                    (ADVP-TMP-1 (-NONE-:[615..615] *T*)))))))))
      (,:[615..616] ,)
      (SBAR-ADV (IN:[618..626] although)
        (S
          (NP-SBJ-3 (PRP$:[627..630] its) (NN:[631..637] ligand))
          (VP (VBZ:[638..641] has)
            (ADVP (RB:[642..645] not) (RB:[646..649] yet))
            (VP (VBN:[650..654] been)
              (VP (VBN:[655..665] identified)
                (NP-3 (-NONE-:[665..665] *))))))))
    (.:[665..666] .)))

;sentence 6 Span:667..911
;We report here that the DR3  gene locus is tandemly duplicated on human
;chromosome band 1p36.2-p36.3 and that  these genes are hemizygously deleted
;and/or translocated to another chromosome  in neuroblastoma (NB) cell lines
;with amplified MYCN.
;[691..694]:gene-rna:"DR3"
;[755..767]:variation-location:"1p36.2-p36.3"
;[794..814]:variation-type:"hemizygously deleted"
;[822..834]:variation-type:"translocated"
;[861..874]:malignancy-type:"neuroblastoma"
;[876..878]:malignancy-type:"NB"
;[896..905]:variation-type:"amplified"
;[906..910]:gene-rna:"MYCN"
(SENT
  (S
    (NP-SBJ (PRP:[667..669] We))
    (VP (VBP:[670..676] report)
      (ADVP (RB:[677..681] here))
      (SBAR
        (SBAR (IN:[682..686] that)
          (S
            (NP-SBJ-1 (DT:[687..690] the) (NN:[691..694] DR3)
                      (NN:[696..700] gene) (NN:[701..706] locus))
            (VP (VBZ:[707..709] is)
              (ADVP (RB:[710..718] tandemly))
              (VP (VBN:[719..729] duplicated)
                (NP-1 (-NONE-:[729..729] *))
                (PP (IN:[730..732] on)
                  (NP
                    (NP (JJ:[733..738] human) (NN:[739..749] chromosome)
                        (NN:[750..754] band)
                      (NML-2 (CD:[755..756] 1))
                      (NN:[756..761] p36.2))
                    (PP (HYPH:[761..762] -)
                      (NP
                        (NML-2 (-NONE-:[762..762] *P*))
                        (NN:[762..767] p36.3)))))))))
        (CC:[768..771] and)
        (SBAR (IN:[772..776] that)
          (S
            (NP-SBJ-3 (DT:[778..783] these) (NNS:[784..789] genes))
            (VP (VBP:[790..793] are)
              (VP
                (VP
                  
                  (ADVP (RB:[794..806] hemizygously))
                  (VBN:[807..814] deleted)
                  (NP-3 (-NONE-:[814..814] *)))
                (CC:[815..821] and/or)
                (VP (VBN:[822..834] translocated)
                  (NP-3 (-NONE-:[834..834] *))
                  (PP (TO:[835..837] to)
                    (NP (DT:[838..845] another) (NN:[846..856] chromosome))))
                (PP-LOC (IN:[858..860] in)
                  (NP
                    (NP
                      (NML
                        (NML (NN:[861..874] neuroblastoma))
                        (NML (-LRB-:[875..876] -LRB-) (NN:[876..878] NB)
                             (-RRB-:[878..879] -RRB-)))
                      (NN:[880..884] cell) (NNS:[885..890] lines))
                    (PP (IN:[891..895] with)
                      (NP (VBN:[896..905] amplified) (NN:[906..910] MYCN)))))))))))
    (.:[910..911] .)))

;sentence 7 Span:912..1142
;Duplication of at least a  portion of the DR3 gene, including the
;extracellular and transmembrane regions  but not the cytoplasmic domain, was
;demonstrated by both fluorescence in situ  hybridization and genomic Southern
;blotting.
;[912..923]:variation-type:"Duplication"
;[954..957]:gene-rna:"DR3"
(SENT
  (S
    (NP-SBJ-2
      (NP (NN:[912..923] Duplication))
      (PP (IN:[924..926] of)
        (NP
          (NP
            (NP
              (ADJP (IN:[927..929] at) (JJS:[930..935] least))
              (DT:[936..937] a) (NN:[939..946] portion))
            (PP (IN:[947..949] of)
              (NP (DT:[950..953] the) (NN:[954..957] DR3) (NN:[958..962] gene))))
          (,:[962..963] ,)
          (VP (VBG:[964..973] including)
            (NP
              (NP (DT:[974..977] the)
                (NML
                  (NML (JJ:[978..991] extracellular)
                    (NML-1 (-NONE-:[991..991] *P*)))
                  (CC:[992..995] and)
                  (NML (JJ:[996..1009] transmembrane)
                    (NML-1 (NNS:[1010..1017] regions)))))
              (CONJP (CC:[1019..1022] but) (RB:[1023..1026] not))
              (NP (DT:[1027..1030] the) (JJ:[1031..1042] cytoplasmic)
                  (NN:[1043..1049] domain)))))))
    (,:[1049..1050] ,)
    (VP (VBD:[1051..1054] was)
      (VP (VBN:[1055..1067] demonstrated)
        (NP-2 (-NONE-:[1067..1067] *))
        (PP-MNR (IN:[1068..1070] by)
          (NP (CC:[1071..1075] both)
            (NP (NN:[1076..1088] fluorescence)
              (ADJP (FW:[1089..1091] in) (FW:[1092..1096] situ))
              (NN:[1098..1111] hybridization))
            (CC:[1112..1115] and)
            (NP (JJ:[1116..1123] genomic) (JJ:[1124..1132] Southern)
                (NN:[1133..1141] blotting))))))
    (.:[1141..1142] .)))

;sentence 8 Span:1143..1273
;In most NB cell lines, both the DR3  and the DR3L sequences are
;simultaneously deleted and/or translocated to another  chromosome.
;[1151..1153]:malignancy-type:"NB"
;[1175..1178]:gene-rna:"DR3"
;[1188..1192]:gene-rna:"DR3L"
;[1222..1229]:variation-type:"deleted"
;[1237..1249]:variation-type:"translocated"
(SENT
  (S
    (PP-LOC (IN:[1143..1145] In)
      (NP (JJS:[1146..1150] most) (NN:[1151..1153] NB) (NN:[1154..1158] cell)
          (NNS:[1159..1164] lines)))
    (,:[1164..1165] ,)
    (NP-SBJ-2 (CC:[1166..1170] both)
      (NP (DT:[1171..1174] the) (NN:[1175..1178] DR3)
        (NML-1 (-NONE-:[1178..1178] *P*)))
      (CC:[1180..1183] and)
      (NP (DT:[1184..1187] the) (NN:[1188..1192] DR3L)
        (NML-1 (NNS:[1193..1202] sequences))))
    (VP (VBP:[1203..1206] are)
      (ADVP (RB:[1207..1221] simultaneously))
      (VP
        (VP (VBN:[1222..1229] deleted)
          (NP-2 (-NONE-:[1229..1229] *)))
        (CC:[1230..1236] and/or)
        (VP (VBN:[1237..1249] translocated)
          (NP-2 (-NONE-:[1249..1249] *))
          (PP (TO:[1250..1252] to)
            (NP (DT:[1253..1260] another) (NN:[1262..1272] chromosome))))))
    (.:[1272..1273] .)))

;sentence 9 Span:1274..1421
;Finally, DR3/ Wsl-1 protein expression is quite variable among these  NB cell
;lines, with very low or undetectable levels in 7 of 17 NB cell lines.
;[1283..1286]:gene-protein:"DR3"
;[1288..1293]:gene-protein:"Wsl-1"
;[1344..1346]:malignancy-type:"NB"
;[1407..1409]:malignancy-type:"NB"
(SENT
  (S
    (ADVP (RB:[1274..1281] Finally))
    (,:[1281..1282] ,)
    (NP-SBJ
      (NML (NN:[1283..1286] DR3) (SYM:[1286..1287] /) (NN:[1288..1293] Wsl-1))
      (NN:[1294..1301] protein) (NN:[1302..1312] expression))
    (VP (VBZ:[1313..1315] is)
      (ADJP-PRD (RB:[1316..1321] quite) (JJ:[1322..1330] variable))
      (PP (IN:[1331..1336] among)
        (NP (DT:[1337..1342] these) (NN:[1344..1346] NB) (NN:[1347..1351] cell)
            (NNS:[1352..1357] lines)))
      (,:[1357..1358] ,)
      (PP (IN:[1359..1363] with)
        (NP
          (NP
            (NP
              (ADJP (RB:[1364..1368] very) (JJ:[1369..1372] low))
              (NML-1 (-NONE-:[1372..1372] *P*)))
            (CC:[1373..1375] or)
            (NP (JJ:[1376..1388] undetectable)
              (NML-1 (NNS:[1389..1395] levels))))
          (PP-LOC (IN:[1396..1398] in)
            (NP
              (NP (CD:[1399..1400] 7))
              (PP (IN:[1401..1403] of)
                (NP (CD:[1404..1406] 17) (NN:[1407..1409] NB)
                    (NN:[1410..1414] cell) (NNS:[1415..1420] lines))))))))
    (.:[1420..1421] .)))

;section 10 Span:1425..1469
;PMID: 9615223 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1425..1429] PMID) (::[1429..1430] :) (CD:[1431..1438] 9615223)
        (NN:[1439..1440] -LSB-) (NNP:[1440..1446] PubMed) (::[1447..1448] -)
        (NN:[1449..1456] indexed) (IN:[1457..1460] for)
        (NNP:[1461..1469] MEDLINE-RSB-)))
